Association between the progression of immunoglobulin A nephropathy and a controlled status of hypertension in the first year after diagnosis
Tae Ryom Oh, Hong Sang Choi, Se Won Oh, Jieun Oh, Dong Won Lee, Chang Seong Kim, Seong Kwon Ma, Soo Wan Kim, Eun Hui Bae,
Korean J Intern Med. 2022;37(1):146-153. Published online 2021 Apr 8 DOI: https://doi.org/10.3904/kjim.2020.205
Citations to this article as recorded by 
Underlying Mechanisms and Treatment of Hypertension in Glomerular Diseases
Sahar H. Koubar, Alejandro Garcia-Rivera, Muner M. B. Mohamed, John E. Hall, Michael E. Hall, Mohamed Hassanein
Current Hypertension Reports.2024; 26(3): 119. CrossRef
Blood and urine biomarkers of disease progression in IgA nephropathy
Zhi-Yu Duan, Chun Zhang, Xiang-Mei Chen, Guang-Yan Cai
Biomarker Research.2024;[Epub] CrossRef
Machine learning-based 2-year risk prediction tool in immunoglobulin A nephropathy
Yujeong Kim, Jong Hyun Jhee, Chan Min Park, Donghwan Oh, Beom Jin Lim, Hoon Young Choi, Dukyong Yoon, Hyeong Cheon Park
Kidney Research and Clinical Practice.2024; 43(6): 739. CrossRef
Urinary GADD45G Protein Excretion Is Associated with IgA Nephropathy Progression
Min-Jeong Lee, Hyunee Yim, Ji Eun Park, Inwhee Park, Heungsoo Kim, Gyu-Tae Shin
Biomedicines.2024; 12(12): 2846. CrossRef
Evaluating Progression Risk in Patients With Immunoglobulin A Nephropathy
Daniel C. Cattran, Jürgen Floege, Rosanna Coppo
Kidney International Reports.2023; 8(12): 2515. CrossRef
Clinicopathological features, risk factors, and outcomes of immunoglobulin A nephropathy associated with hepatitis B virus infection
Kailong Wang, Zhikai Yu, Yinghui Huang, Ke Yang, Ting He, Tangli Xiao, Yanlin Yu, Yan Li, Liang Liu, Jiachuan Xiong, Jinghong Zhao
Journal of Nephrology.2021; 34(6): 1887. CrossRef